Cabaletta Bio, Inc. SEC filings CABA

Cabaletta Bio, Inc. has 448 filings in SEC EDGAR's recent list, going back to Dec 10, 2018. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Cabaletta Bio, Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Other events
Sep 14, 2026 Sep 14, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 11, 2026 Jun 9, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 3, 2026 Jun 3, 2026
8-K Current report
Results of operations
May 14, 2026 May 14, 2026
8-K Current report
Regulation FD disclosure, Other events
May 14, 2026 May 14, 2026
8-K Current report
Material agreement, Results of operations, Other events
May 4, 2026 May 4, 2026
8-K Current report
Other events
May 4, 2026 May 4, 2026
8-K Current report
Other events
Apr 20, 2026 Apr 20, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Mar 23, 2026 Mar 23, 2026
8-K Current report
Regulation FD disclosure, Other events
Jan 12, 2026 Jan 12, 2026
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
8-K Current report
Other events
Oct 29, 2025 Oct 29, 2025
8-K Current report
Regulation FD disclosure, Other events
Oct 27, 2025 Oct 27, 2025
8-K Current report
Regulation FD disclosure, Other events
Oct 9, 2025 Oct 9, 2025
8-K Current report
Regulation FD disclosure
Sep 3, 2025 Sep 3, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Material agreement, Other events
Jun 12, 2025 Jun 11, 2025
8-K Current report
Agreement ended, Regulation FD disclosure, Other events
Jun 11, 2025 Jun 11, 2025
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 10, 2025 Jun 9, 2025
8-K Current report
Officer or director change
May 19, 2025 May 15, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 15, 2025 May 15, 2025
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
8-K/A Amended current report
Regulation FD disclosure, Other events
Feb 18, 2025 Feb 18, 2025
8-K Current report
Regulation FD disclosure, Other events
Feb 18, 2025 Feb 18, 2025
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jan 13, 2025 Jan 13, 2025
8-K Current report
Regulation FD disclosure, Other events
Nov 18, 2024 Nov 18, 2024
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
8-K Current report
Regulation FD disclosure, Other events
Oct 7, 2024 Oct 7, 2024
8-K Current report
Material agreement
Sep 30, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 8, 2024 Aug 8, 2024
8-K Current report
Regulation FD disclosure, Other events
Jun 14, 2024 Jun 14, 2024
8-K Current report
Shareholder vote results
Jun 4, 2024 Jun 3, 2024
8-K Current report
Results of operations, Regulation FD disclosure
May 15, 2024 May 15, 2024
8-K Current report
Results of operations
Mar 21, 2024 Mar 21, 2024
8-K Current report
Regulation FD disclosure
Mar 20, 2024 Mar 20, 2024
8-K Current report
Regulation FD disclosure, Other events
Feb 1, 2024 Feb 1, 2024
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jan 8, 2024 Jan 8, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 9, 2023 Nov 9, 2023
8-K Current report
Regulation FD disclosure, Other events
Nov 6, 2023 Nov 6, 2023
8-K Current report
Regulation FD disclosure, Other events
Oct 2, 2023 Oct 2, 2023
8-K Current report
Regulation FD disclosure
Sep 5, 2023 Sep 5, 2023
8-K Current report
Regulation FD disclosure, Other events
Aug 22, 2023 Aug 18, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Jul 24, 2023 Jul 21, 2023
8-K Current report
Officer or director change, Shareholder vote results
Jun 1, 2023 Jun 1, 2023
8-K Current report
Other events
May 22, 2023 May 22, 2023
8-K Current report
Material agreement, Other events
May 18, 2023 May 17, 2023
8-K Current report
Regulation FD disclosure, Other events
May 16, 2023 May 16, 2023
8-K Current report
Regulation FD disclosure
May 16, 2023 May 16, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
8-K Current report
Regulation FD disclosure, Other events
May 2, 2023 May 2, 2023
8-K Current report
Regulation FD disclosure, Other events
May 1, 2023 May 1, 2023
8-K Current report
Regulation FD disclosure, Other events
Mar 31, 2023 Mar 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Mar 16, 2023 Mar 16, 2023
8-K Current report
Other events
Mar 6, 2023 Mar 6, 2023
8-K Current report
Regulation FD disclosure
Jan 9, 2023 Jan 9, 2023
8-K Current report
Material agreement, Other events
Dec 12, 2022 Dec 7, 2022
8-K Current report
Other events
Dec 8, 2022 Dec 8, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Nov 10, 2022 Nov 10, 2022
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Oct 11, 2022 Oct 7, 2022
8-K Current report
Regulation FD disclosure, Other events
Sep 12, 2022 Sep 10, 2022
8-K Current report
Other events
Aug 29, 2022 Aug 29, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Aug 11, 2022 Aug 11, 2022
8-K Current report
Shareholder vote results
Jun 2, 2022 Jun 1, 2022
8-K Current report
Regulation FD disclosure, Other events
May 18, 2022 May 18, 2022
8-K Current report
Results of operations
May 12, 2022 May 12, 2022
8-K Current report
Regulation FD disclosure
May 2, 2022 May 2, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Mar 17, 2022 Mar 17, 2022
8-K/A Amended current report
Regulation FD disclosure
Mar 14, 2022 Mar 3, 2022
8-K Current report
Regulation FD disclosure
Mar 3, 2022 Mar 3, 2022
8-K Current report
Other events
Mar 1, 2022 Mar 1, 2022
8-K Current report
Regulation FD disclosure
Jan 10, 2022 Jan 10, 2022
8-K Current report
Regulation FD disclosure, Other events
Dec 14, 2021 Dec 14, 2021
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Nov 1, 2021 Nov 1, 2021
8-K Current report
Regulation FD disclosure, Other events
Aug 18, 2021 Aug 18, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Aug 5, 2021 Aug 5, 2021
8-K Current report
Officer or director change
Jun 28, 2021 Jun 24, 2021
8-K Current report
Shareholder vote results, Regulation FD disclosure
Jun 3, 2021 Jun 1, 2021
8-K Current report
Results of operations, Regulation FD disclosure, Other events
May 3, 2021 May 3, 2021
8-K Current report
Regulation FD disclosure
Apr 6, 2021 Apr 6, 2021
8-K Current report
Results of operations
Mar 16, 2021 Mar 16, 2021
8-K Current report
Other events
Dec 8, 2020 Dec 8, 2020
8-K Current report
Results of operations
Nov 10, 2020 Nov 10, 2020
8-K Current report
Results of operations
Aug 6, 2020 Aug 6, 2020
8-K Current report
Shareholder vote results, Regulation FD disclosure
Jun 3, 2020 Jun 2, 2020
8-K Current report
Material agreement
May 28, 2020 May 28, 2020
8-K Current report
Results of operations
May 12, 2020 May 12, 2020
8-K Current report
Other events
May 6, 2020 May 6, 2020
8-K Current report
Results of operations
Mar 30, 2020 Mar 30, 2020
8-K Current report
Regulation FD disclosure
Feb 20, 2020 Feb 20, 2020
8-K Current report
Other events
Jan 29, 2020 Jan 29, 2020
8-K Current report
Regulation FD disclosure
Jan 10, 2020 Jan 10, 2020
8-K Current report
Bylaw or fiscal year change
Oct 30, 2019 Oct 29, 2019

Showing 95 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
CABA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Philadelphia, PA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1759138

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.